# GLORIA-AF Registry Program - Second and Third Phases

> **NCT01468701** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 37235 (actual)

## Conditions studied

- Stroke
- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01468701
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-07
- **Primary completion:** 2020-01-10
- **Final completion:** 2020-01-10
- **Target enrollment:** 37235 (ACTUAL)
- **Last updated:** 2021-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468701, "GLORIA-AF Registry Program - Second and Third Phases". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01468701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*